thoughts my so IRADIMED weeks. being be and XX would CEO after background results, new this you part and initial few on first few good as a my excited I also to little the moments a of to of job the about IRADIMED’s I’m you, everyone. my telling about for bit present and Since performance a spend is share a Thank morning, thought I opportunity why
for are every IRADIMED’s team improving Everyone no of a here outstanding and we critical to that Roger in their truly at it like for complement would building first business. should products and I recognized Susi work do care. the the IRADIMED say day. be proud I is to patient value believe growing exaggeration
little positions I senior before and Natus general public healthcare holding for companies about IRADIMED officer XX at Now at recently, an XM come to my Healthcare and and a I background. Medical Medtronic and of after over was years. Most executive was manager that. in
learned and I the corporate product to among therapy I management. ranging have best served carry process my and with practices, this, to me knowledge the confident operations I’m from the into IRADIMED lead to all M&A, future. much and to and in med companies development, tech. in development, With roles from and business abilities in marketing, respected strategy team most of
opportunity have now Now I since why IRADIMED? with interact was question to everyone. question you. that a So joining I chose join me IRADIMED, address few common let of had for One to
As compelling I company, a struck particularly studied few things me. the
during care to novel high patient developed solve technologies in very challenges levels procedures. MRI has providing IRADIMED real of First,
facilitate higher risk unnecessary The excessive date undergoing devices otherwise care far our MRI standard while to in IRADIMED an developed to and be would pipeline those scan. and exposed of patients who for a
the receive everywhere receive Our products in in routinely allow the else care patients level MRI they to hospital. as same high of the
higher extremely product profitability. from to gross fees process, track size. of IRADIMED profitability, the the and this a leads which record is for is mind. accomplished In strong margins large growth stems a rare has of enjoys financial with development my part sustainable a view, company IRADIMED This which success manufacturability Second, and in to
challenges to deep to It knowledge how of IRADIMED leverage the plan our understanding strength presents MRI technologies product knowledge current overcome products. the the we and potential of We our day set challenges of pipeline to as how so. has our Finally, novel core current at environment. tremendous at I MRI scalability of work the and and every believe to is do that overcome applying and future that our of is the continue the and technology and of
why to are part There played to out into my that the reasons other many those essence be this laid team. capture IRADIMED the I’ve of decision role, but accept just excited of I’m
as company very in also traveled been our transition. collective to continuing mid-August, through our positive, meeting their culture. and My I I’ve and and I gain absorbing meet possible Now an my much understanding to with initial since this and with team IRADIMED customers of joining products eyes. look our to as have are about numerous thoughts forward
Through this few to we structure have work about and we priorities changes made how and early the teams, with think our a staffing.
Some of will evident you more these to than be others.
second more priority up the launch System of this the one delay order changes of spend smaller development. half in that significant will we year. next phases time are instance, of Detection different For Instead, until is projects the Ferro-magnetic wrapping of several to the currently
other work to maintain accelerate I the room investments. need spent already also much have conclusion these we larger supportive cleaner trajectory for time learning sensible on and staffing healthy levels. growth and on My projects is our IRADIMED, that much will systems thinking at projects. work make the processes, and a Concluding make to path about to
staffing at being work investments thoughtful how with investment We we time be my and the toward the regulatory and team far, our areas. impact to in right have and systems these we engineering decisions. act in needed eye amount several these an ensuring always financial the about made the plan of of with in is Through IT our areas, thus right identified
team, diluted of per third share $X.XX $XXX,XXX last which about X% increase quarter year’s Now which year on to in a the validate move the is positive considering I entire happy am both quarter. million, third quarter and the to financial summarize the strong benefit third the events reasons last for diligence and sequentially. These XX% the to ethic income very of over the XXXX will are nearly revenue I I’m due quarter. and the why excited IRADIMED third XXXX, in when net quarter future. of results tax XX work the report GAAP was up is and very
a to functional all came end quarter after area continue derisks a it the perspective, the the well Now the transition, teams to of relates toward to working very from as spent events transition. perspective, the resolution one been the well warning of obviously my occur to just bigger for adjusting perform countless regulatory From who resolution. during This helpful as action. have and This as company that also all hours was resolution have the letter. relief a big with of that its
QX notified probable. on needs quickly as has completely frequent conclude us now continue the Mark a that much this and body ensure we the toward as we doing for to With leading behind us, our positive information CE is We the resolution it notified actively patient positive, vital are our our body our in remain with regaining dialogue warning working can to matter The is signs and letter favor. monitor. believe as to possible as
Mark. that we Until to to customer CE shipping anticipate regaining continue the then, we on orders upon immediately hold
CE EU shipments of held calls, marking. explained being on are into the lapse previous by XXXX As only in countries this
impact the not Additionally, to are this does safety in that monitors already the not concerns and field. patient due this is
on Now to engineering.
mentioned the projects we wrapping our I development next-generation development As smaller as our pump. earlier, are on focusing near-term enhancements, as IV up priorities, of well revising efforts some the and continuing
the be much to expect we remains efforts. slate, efforts development IV we next-generation development our our our of more and Related cleaner to the forward. priority, With continue in this all pump, effective development going
fourth and will I full summarize XXXX. quickly for the quarter Now financial guidance our year the
full now considering updated later date per of to XX.X XXXX, these and we million revenue year reflect of movement diluted our full to diluted earnings $X.XX quarter the share to the earnings XXXX. to year expect to fourth FMD items, report million, the we in GAAP of $X.XX per XX.X and non-GAAP until to share from $X.XX. $X.XX, XXXX guidance For of the actual After
guidance earnings to share $X.XX million revenue, to to million our $X.XX This to $X.XX. XX.X range diluted GAAP of share per compares of $X.XX, of previous diluted non-GAAP earnings per of XX.X and
morning, our the negatively costs expected GAAP by associated earnings earnings impact diluted $X.XX share. stated this by $X.XX with per to CEO full per release diluted non-GAAP transition are year As in and share
$X.XX. For by the fourth and share XX.X per fourth expect XXXX, the Costs revenue quarter, by $X.XX to of non-GAAP to earnings million share per diluted earnings of impact we and GAAP million, share quarter $X.XX. negatively with CEO non-GAAP are expected associated diluted $X.XX to of earnings $X.XX $X.XX, earnings diluted GAAP per to transition XX.X
call a the I discussion the for of sales to over will Brent organization. turn now
